We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.2B
AUM Growth
+$250M
Cap. Flow
+$154M
Cap. Flow %
12.9%
Top 10 Hldgs %
53.97%
Holding
74
New
14
Increased
12
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$11.5M
2
RGNX icon
Regenxbio
RGNX
+$7.68M
3
WOLF icon
Wolfspeed
WOLF
+$6.03M
4
CTLT
CATALENT, INC.
CTLT
+$4.39M
5
LAMR icon
Lamar Advertising Co
LAMR
+$3.61M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.69M
2
WTFC icon
Wintrust Financial
WTFC
+$4.44M
3
CLF icon
Cleveland-Cliffs
CLF
+$2.4M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$1.75M
5
SLN
Silence Therapeutics
SLN
+$155K

Sector Composition

Rank Sector Weight
1 Financials 14.83%
2 Technology 11.85%
3 Consumer Staples 3.95%
4 Consumer Discretionary 3.9%
5 Materials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
51
BioMarin Pharmaceuticals
BMRN
$12.3B
$2.68M 0.22%
30,953
– –
GME icon
52
PUT
GameStop
GME
$8.59B
$2.42M 0.2%
+100,000
New +$2.25M
UBER icon
53
CALL
Uber
UBER
$153B
$2.16M 0.18%
+50,000
New +$1.86M
ASA
54
ASA Gold and Precious Metals
ASA
$1.09B
$1.82M 0.15%
122,351
– –
CLF icon
55
CALL
Cleveland-Cliffs
CLF
$6.99B
$1.68M 0.14%
+100,000
New +$1.59M
NTLA icon
56
Intellia Therapeutics
NTLA
$1.67B
$1.09M 0.09%
26,646
– –
CRSP icon
57
CRISPR Therapeutics
CRSP
$5.17B
$1.06M 0.09%
18,876
– –
MPT
58
Medical Properties Trust
MPT
$2.82B
$926K 0.08%
100,000
– –
RARE icon
59
Ultragenyx Pharmaceutical
RARE
$2.55B
$733K 0.06%
15,885
– –
WVE icon
60
Wave Life Sciences
WVE
$1.2B
$702K 0.06%
192,722
– –
CTLT
61
CALL
DELISTED
CATALENT, INC.
CTLT
$429K 0.04%
+9,900
New +$435K
EDIT icon
62
Editas Medicine
EDIT
$442M
$237K 0.02%
28,797
– –
AFMD
63
DELISTED
Affimed
AFMD
– –
-10,000
Closed -$74.6K
CLF icon
64
Cleveland-Cliffs
CLF
$6.99B
– –
-151,500
Closed -$2.4M
CVNA icon
65
CALL
Carvana
CVNA
$77.9B
– –
-750,000
Closed -$1.47M
DXCM icon
66
CALL
DexCom
DXCM
$32B
– –
-100,000
Closed -$11.6M
DXCM icon
67
DexCom
DXCM
$32B
– –
-100
Closed -$12.1K
GDX icon
68
CALL
VanEck Gold Miners ETF
GDX
$27.4B
– –
-200,000
Closed -$6.47M
KRE icon
69
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
– –
-40,000
Closed -$1.75M
SLN
70
Silence Therapeutics
SLN
$564M
– –
-25,000
Closed -$155K
TDOC icon
71
CALL
Teladoc Health
TDOC
$1.3B
– –
-150,000
Closed -$3.88M
UBER icon
72
PUT
Uber
UBER
$153B
– –
-150,000
Closed -$4.75M
WTFC icon
73
Wintrust Financial
WTFC
$10.7B
– –
-60,900
Closed -$4.44M
FSR
74
CALL
DELISTED
Fisker Inc.
FSR
– –
-300,000
Closed -$1.84M
1 2
3

Similar funds

OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SL
SWF LLC Omaha, Nebraska $1.15B AUM 6.36% 1-Year Est. Return

WS Management's Q2 2023 Portfolio in Review

As of Q2 2023, WS Management held 74 positions worth $1.2B, up 26% from $946M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

WS Management deployed $154M of net new capital in Q2 2023, opening 14 new positions and adding to 12 existing holdings. Its largest new stake was Wolfspeed: 118,400 shares worth $6.58M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $6.69M trimmed.

  • WS Management's largest Q2 2023 buy was Wolfspeed: 118,400 shares worth $6.58M.
  • WS Management added most to NVIDIA in Q2 2023, an estimated $11.5M increase.
  • WS Management's biggest Q2 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $6.69M.
  • WS Management fully exited Wintrust Financial in Q2 2023, selling an estimated $4.44M.
  • WS Management's ten largest holdings make up 54% of its $1.2B portfolio in Q2 2023.
  • WS Management opened 14 new positions and closed 12 in Q2 2023.
  • WS Management's portfolio value rose 26% quarter-over-quarter to $1.2B.

Based on WS Management's 13F filing for Q2 2023, filed 10 Aug 2023.